Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

688
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
688
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

575
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
575
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Lung function impairment at pulmonary TB and HIV/TB diagnosis: a South African cross-sectional cohort analysis.

BMJ open respiratory research·2026
Same author

Functional analysis of type VII secretion system links to host immune evasion mechanism in <i>Mycobacterium tuberculosis</i>.

Frontiers in cellular and infection microbiology·2026
Same author

Long-term Sequelae of Pulmonary Tuberculosis: A Narrative Review.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

NR4A1 limits CD8<sup>+</sup> T Cell effector responses and protection in tuberculosis.

Research square·2026
Same author

NR4A1 limits CD8⁺ T Cell effector responses and protection in tuberculosis.

bioRxiv : the preprint server for biology·2026
Same author

Ly6G<sup>+</sup> granulocytes-derived IL-17 limits protective host responses and promotes tuberculosis pathogenesis.

eLife·2026

相关实验视频

Updated: Feb 28, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K

在肺结核肺结核治疗结果的补充分析.

Nathella Pavan Kumar1,2, Arul Nancy P1,3, Syed Hissar1

  • 1Indian Council of Medical Research (ICMR)- National Institute for Research in Tuberculosis, Chennai, India.

Frontiers in immunology
|February 27, 2026
PubMed
概括

补体系统激活的升高,特别是通过经典途径,与结核病治疗结果不佳有关. 补充失调可以预测个体有风险对结核病治疗产生不良反应.

关键词:
补充蛋白质是一种补充蛋白质.多重复 ELISA 测试方法预后标志物 预后标志物结核病是一种肺结核病.不利的结核病治疗结果.

更多相关视频

Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis
07:32

Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis

Published on: March 28, 2025

1.3K
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

6.2K

相关实验视频

Last Updated: Feb 28, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K
Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis
07:32

Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis

Published on: March 28, 2025

1.3K
Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

6.2K

科学领域:

  • 免疫学 免疫学 免疫学
  • 传染性疾病 传染性疾病
  • 生物化学 生物化学

背景情况:

  • 补体系统对于对抗Mycobacterium tuberculosis的免疫反应至关重要.
  • 补充活性失衡可能导致免疫反应不足或过度炎症,影响结核病治疗结果.

研究的目的:

  • 为了研究基线补充资料和肺结核 (TB) 患者不良治疗反应之间的关联.
  • 为了确定结核病治疗结果的潜在预后标志物.

主要方法:

  • 用Magpix多重细胞因子测定法测量补充成分和调节性蛋白质的血水平.
  • 分析了一组结核病患者,治疗结果不佳 (n=68) 和无病对照组 (n=108).
  • 测量是在抗结核病治疗的基线 (治疗前) 和第二个月进行的.

主要成果:

  • 与对照组相比,结核病患者表现不佳的结核病患者在两个时间点的C3,C3b,C4b,C5,C5a和C1q水平显著更高.
  • 在治疗结果不佳的患者中观察到B因子和H因子水平降低.
  • 回归分析表明,高水平的C3,C3b,C4b,C5,C5a和C1q与不良结核病治疗结果的风险增加有关.

结论:

  • 早期和持续的补充激活,特别是通过经典途径,与结核病患者的不良结果相关.
  • 补充失调显示出潜在的预后标记,用于识别可能对结核病治疗反应差的个体.